Evidence map›Paper›PMID 34366620›Full record

ReviewWorld journal of gastroenterology2021

Recent advances in gastrointestinal cancers.

Natacha Bordry, Christoforos Astaras, Marie Ongaro, Nicolas Goossens, Jean Louis Frossard, Thibaud Koessler

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Bioinformatic Analysis ofInternational journal of molecular sciences · 2024
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natacha BordryDepartment of Oncology, University Hospital of Geneva (HUG), Genève 1205, Switzerland.
Christoforos AstarasDepartment of Oncology, University Hospital of Geneva (HUG), Genève 1205, Switzerland.
Marie OngaroDivison of Gastroenterology and Hepatology, University Hospital of Geneva (HUG), Genève 1205, Switzerland.
Nicolas GoossensDivison of Gastroenterology and Hepatology, University Hospital of Geneva (HUG), Genève 1205, Switzerland.
Jean Louis FrossardDivison of Gastroenterology and Hepatology, University Hospital of Geneva (HUG), Genève 1205, Switzerland.
Thibaud KoesslerDepartment of Oncology, University Hospital of Geneva (HUG), Genève 1205, Switzerland. thibaud.kossler@hcuge.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal cancers occur in a total of eight different locations, each of them with a different standard of care. This article is not an exhaustive review of what has been published in 2020. We have concentrated on the thirteen phase III randomized studies that are practice-changing. All these studies are oral presentations which have been given in one of the four major oncology congresses, namely American Society of Clinical Oncology (ASCO), ASCO gastrointestinal (GI), European Society of Medical Oncology (ESMO) and ESMO-GI. We provide a concise view of these major trials and their main outcomes, and put these results into context.

Indexed as

Gastrointestinal NeoplasmsHumansMedical OncologyGastric cancerGastrointestinalGastrointestinal cancersImmunotherapyPractice changing trials

Identifiers

PMID34366620
PMCPMC8326255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.